Articles

Aprea Therapeutics (APRE) Stock Soars as Wedbush Sets $3 Price Target

Wedbush analyst Robert Driscoll just gave a huge upside target for APRE stock. Here’s why this is significant for the biotech sector. More 

Why Is Marathon Digital (MARA) Stock in the Spotlight Today?

MARA stock investors are cheering after a critical update revealed Marathon is holding a lot of Bitcoin -- and a whole lot of cash, too. More 

Is TSLA Stock a Buy Ahead of the Tesla Stock Split?

Investors should monitor TSLA stock closely as shareholders prepare to vote on a 3-for-1 Tesla stock split on Aug. 4. More 

Why Is Aditxt (ADTX) Stock Up 74% Today?

ADTX stock is soaring after the company reported positive results from a preclinical toxicology test this morning. More 

Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year

BMY stock is up 21% this year. That's impressive compared to the market as a whole, which has entered bear territory, and it has room to grow. More 

SIGA Stock Is in Focus Following U.K. Approval of Monkeypox Treatment

Investors may have assumed SIGA stock would rally on a regulatory green light for SIGA Technologies, but the response has been lackluster. More 

Shiba Inu Price Predictions: Where Will a New Vision Take the SHIB Crypto?

Shiba Inu price predictions are in the spotlight after a lead developer behind SHIB shared plans for potential new features. More